usbiostock2018-07-31 22:32
$Asterias Biotherapeutics, Inc. Common Series A(AST)$ 公司公布AST-OPC1治疗急性脊髓损伤临床1/2期试验12个月数据(Cohort3,4)。查看全文
usbiostock2018-07-17 19:50
$Asterias Biotherapeutics, Inc. Common Series A(AST)$ 公司公布AST-OPC1治疗急性脊髓损伤临床1/2期试验6个月中期数据。查看全文
usbiostock2018-07-11 22:48
$Asterias Biotherapeutics, Inc. Common Series A(AST)$ 公司宣布AST-VAC2治疗非小细胞肺癌(NSCLC)临床试验已经完成第一名患者治疗(每周注射1千万个细胞,每周一次,共5周),目前患者安全性和耐受性良好。安全委员会同意按照现有流程继续该临床试验。查看全文
usbiostock2018-06-06 09:14
$Asterias Biotherapeutics, Inc. Common Series A(AST)$ 数据监测委员会完成AST-OPC1治疗急性脊髓损伤临床1/2期试验的安全性数据监测,建议按照现有的试验流程继续完成该临床试验。目前该试验已完成25例患者的治疗(外加之前5例)。治疗6个月数据(包括Cohort 5)预计在2018年第2季度晚期或第3季...查看全文
美股医药Z博士2018-02-27 11:12
$Asterias Biotherapeutics, Inc. Common Series A(AST)$ 给大家推荐一个短线的小票。该公司使用干细胞治疗脊髓损伤,公司计划于2月公布1/2期试验中几个cohort的结果。根据以往的结果观察,此次公布的数据大概率是好结果。上周五有投行提高该股的目标价,略微拉升了一下。不知道今晚会不会公布数据...查看全文
$海星生物治疗(AST)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-03-14 AccNo: 0001493152-19-003320 Size: 40 KB 网页链接
$海星生物治疗(AST)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-12 AccNo: 0000919574-19-002300 Size: 98 KB 网页链接
$海星生物治疗(AST)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-12 AccNo: 0001493152-19-003107 Size: 47 KB 网页链接
$海星生物治疗(AST)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Filed: 2019-03-08 AccNo: 0000876661-19-000203 Size: 4 KB 网页链接
$海星生物治疗(AST)$ 8-K - Current report Filed: 2019-03-08 AccNo: 0001493152-19-003027 Size: 236 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3...
$海星生物治疗(AST)$ 425 - Prospectuses and communications, business combinations Filed: 2019-03-01 AccNo: 0001140361-19-004237 Size: 485 KB 网页链接
$海星生物治疗(AST)$ 8-K - Current report Filed: 2019-03-01 AccNo: 0001140361-19-004236 Size: 485 KBItem 8.01: Other Events 网页链接
$海星生物治疗(AST)$ 425 - Prospectuses and communications, business combinations Filed: 2019-02-28 AccNo: 0001140361-19-004114 Size: 17 KB 网页链接
$海星生物治疗(AST)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2019-02-04 AccNo: 0001493152-19-001349 Size: 5 MB 网页链接
$海星生物治疗(AST)$ 425 - Prospectuses and communications, business combinations Filed: 2019-01-24 AccNo: 0001140361-19-001494 Size: 49 KB 网页链接